Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 4, 2008, Pages 338-342

  Kosai, Kosuke ^a,b,c   Seki, Masafumi ^a,b,c   Yanagihara, Katsunori ^b   Nakamura, Shigeki ^a,b   Kurihara, Shintaro ^b   Izumikawa, Koichi ^a,b   Kakeya, Hiroshi ^a,b   Yamamoto, Yoshihiro ^a,b   Tashiro, Takayoshi ^a,b   Kohno, Shigeru ^a,b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KITAKYUSHU CITY YAHATA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; RANTES;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFLUENZA; LEUKOCYTE COUNT; MALE; MIXED INFECTION; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA; REGULATORY MECHANISM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; CHEMOKINE CCL5; FEMALE; HMGB1 PROTEIN; HUMANS; INFLUENZA, HUMAN; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; UP-REGULATION;

EID: 41349091880     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701660486     Document Type: Article

References (22)

1. Mandell, LA, Wunderink, R., Anzueto, A., Bartlett, JG, Campbell, GD and Dean, NC (2007) Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis, 44, p. S27.
2. Woodhead, M., Blasi, F., Ewig, S., Huchon, G., Leven, M. and Ortqvist, A. (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J, 26, pp. 1138-1180.
3. Seki, M., Hashiguchi, K., Kosai, K., Higashiyama, Y., Yanagihara, K. and Kurihara, S. (2006) A patient with fulminant primary influenza pneumonia which developed into secondary bacterial pneumonia. Acta Medica Nagasakiensia, 51, pp. 121-124.
4. Seki, M., Kosai, K., Yanagihara, K., Higashiyama, Y., Kurihara, S. and Izumikawa, K. (2007) Disease severity in patients with simultaneous influenza and bacterial pneumonia. Intern Med, 46, pp. 953-958.
5. Seki, M., Yanagihara, K., Higashiyama, Y., Fukuda, Y., Kaneko, Y. and Ohno, H. (2004) Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J, 24, pp. 143-149.
6. Seki, M., Higashiyama, Y., Tomono, K., Yanagihara, K., Ohno, H. and Kaneko, Y. (2004) Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa. Clin Exp Immunol, 137, pp. 35-40.
7. Abramson, JS, Giebink, G., Mills, EL and Quie, PG. (1981) Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas. J Infect Dis, 143, pp. 836-845.
8. Abramson, JS, Lyles, D., Heller, KA and Bass, DA. (1982) Influenza A virus-induced polymorphonuclear leukocyte dysfunction. Infect Immun, 37, pp. 794-799.
9. Parrish, W. and Ulloa, L. (2007) High-mobility group box-1 isoforms as potential therapeutic targets in sepsis. Methods Mol Biol, 361, pp. 145-162.
10. Mantell, LL, Parrish, W. and Ulloa, L. (2006) HMGB-1 as a therapeutic target for infectious and inflammatory disorders. Shock, 25, pp. 4-11.
11. Yanagihara, K., Otsu, Y., Ohno, H., Higashiyama, Y., Miyazaki, Y. and Hirakata, Y. (2004) Clinical characteristics of pneumonia caused by penicillin resistant and sensitive Streptococcus pneumoniae in Japan. Intern Med, 43, pp. 1029-1033.
12. Yamada, S. and Maruyama, I. (2006) HMGB-1, a novel inflammatory cytokine. Clin Chim Acta, 375, pp. 36-42.
13. Yamada, S., Inoue, K., Yakabe, K., Imaizumi, H. and Maruyama, I. (2003) High mobility group protein-1 (HMGB-1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB-2. Clin Chem, 49, pp. 1535-1537.
14. Taubenberger, JK, Reid, AH, Krafft, AE, Bijwaard, KE and Fanning, TG. (1997) Initial genetic characterization of the 1918 'Spanish' influenza virus. Science, 275, pp. 1793-1796.
15. Reid, AH, Fanning, TG, Hultin, JV and Taubenberger, JK. (1999) Origin and evolution of the 1918 'Spanish' influenza virus hemagglutinin gene. Proc Natl Acad Sci U S A, 96, pp. 1651-1656.
16. Chan, MC, Cheung, CY, Chui, WH, Tsao, SW, Nicholls, JM and Chan, YO (2005) Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res, 6, pp. 135-148.
17. McCullers, JA. (2004) Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J Infect Dis, 190, pp. 519-526.
18. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, JM, Ombrellino, M. and Che, J. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science, 9, pp. 248-251.
19. Park, JS, Svetkauskaite, D., He, Q., Kim, JY, Strassheim, D. and Ishizaka, A. (2004) Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem, 279, pp. 7370-7377.
20. Park, JS, Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, JY and Strassheim, D. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol, 290, p. C917.
21. Andersson, U., Wang, H., Palmblad, K., Aveberger, AC, Bloom, O. and Erlandsson-Harris, H. (2000) High mobility group-1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med, 192, pp. 565-570.
22. Angus, DC, Yang, L., Kong, L., Kellum, JA, Delude, RL and Tracey, KJ (2007) Circulating high-mobility group box-1 (HMGB-1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med, 35, pp. 1061-1067.